OMO. O. Marzan

O. O. Marzan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


O. O. Marzan has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Albumin treatment of critical conditions on the example of pre-eclampsia

    by O. M. Klygunenko, O. V. Kravets, O. O. Zozulya, O. O. Marzan, Yu. O. Ploshchenko, V. A. Sedinkin, D. M. Stanin

    Despite the well-documented physicochemical and pharmacodynamic properties of albumin solutions and the availability of clinical guidelines for their use in critical conditions, several aspects of their application, particularly in the context of pre-eclampsia, remain a matter of clinical debate. Aim: to ascertain the effect of intravenous human albumin solution on the inflammatory process activity in the postpartum period in women with pre-eclampsia. Materials and methods. 60 women aged 18 to 40 years in the third trimester of pregnancy complicated by moderate or severe pre-eclampsia were assigned to 2 groups of 30 patients each according to the prespecified inclusion and exclusion criteria. Group I patients were given a standard therapy after delivery. Group II patients were treated with the same therapy combined with continuous infusions of 20 % albumin solution (8 ml/h – on day 1; 4 ml/h – on days 2 and 3) and furosemide (0.05 mg/kg/h – on day 1; 0.025 mg/kg/h – on days 2 and 3) for 72 hours. Serum concentrations of interleukins (IL)-6 and IL-10 were measured, and the IL-6 / IL-10 ratio (inflammation index) was calculated before the onset of labor, and on days 1 and 3 of the postpartum period. Results. The analysis has shown the inflammatory index of 120 % higher the normal in the third trimester of uncomplicated pregnancy, indicating a slight prenatal increase in inflammatory processes. Moderate or severe pre-eclampsia in the same period has been found to be accompanied by significantly increased IL-6/IL-10 ratios by 523.3–570.0 %, showing the significant activation of inflammatory processes. The use of albumin infusion in combination with low doses of furosemide according to the method developed by us has proven the possibility to correct the inflammatory process activity. So, with infusions on the 1st day postpartum, the IL-6 / IL-10 ratio was decreased and exceeded the norm for non-pregnant women by 866.7 % versus 1696.7 % in Group 1 women. On the 3rd day after childbirth, the inflammatory index exceeded the norm by only 116.7 % with intravenous albumin, while in Group 1 (control), it remained 730.0 % higher than the norm. Conclusions. Intravenous combination of albumin solution with furosemide in the postpartum period according to the authors’ method has helped to significantly reduce the inflammatory index in parturient women with pre-eclampsia.

  • Open Access

    Albumin solution as an important component of intensive infusion therapy in women with preeclampsia

    by O.M. Klygunenko, O.V. Kravets, O.O. Marzan

    The aim of the study is to determine the efficiency and effectiveness of albumin solution in intensive infusion therapy for pregnant women with preeclampsia based on measuring indicators of central and peripheral hemodynamics, body water compartments, and markers of inflammation. 60 women were divided into two groups and examined. The first group (n=30) included women whose average age was 30.06±5.13 years, gestation period – 260.18±6.34 days. 16.7% of women in this group had moderate preeclampsia, 83.3% – severe preeclampsia. Patients of this group received standard intensive infusion therapy according to approved treatment protocols. The second group (n=30) included women, whose average age was 30.62±6.02 years, and pregnancy period 258.75±5.74 days. The patients of this group received intensive infusion therapy, like the women of the first group but in combination with a continuous infusion of a 20% albumin solution (8 ml/h – on the 1 st day; 4 ml/h – on the 2nd and 3rd day) and furosemide (0.05 mg/kg/h – on the 1st day; 0.025 mg/kg/h – on the 2nd and 3rd day) for 72 hours starting from the moment of the end of vaginal delivery or Cesarean section surgery. The comparative analysis showed that the dynamics of changes in the main indicators of homeostasis, hemodynamics, body water compartments and markers of inflammation in parturient women with preeclampsia strongly depend on the type of intensive infusion therapy. In women with preeclampsia, continuous administration of a 20% albumin solution immediately after delivery ensures the normalization of body water compartments till the 7th day of the postpartum period. It is the result of a rapid decrease in the total volume of fluid (by 17.2%, p<0.001 from the baseline) and interstitium (by 31.8%, p<0.001 from the prenatal level). The provided treatment in parturient women with preeclampsia helps to ensure a eukinetic type of blood circulation from the 5th day of the postpartum period already. It is also accompanied by the restoration of adaptation mechanisms that participate in maintaining the proper functioning of the cardiovascular system. The use of albumin and furosemide solution infusion reduces the degree of the background inflammatory process by 3.8 times (according to the index of inflammatory activity IL-6/IL-10) which comes along with preeclampsia.